Bernhard Hofer

DePuy Orthopaedics, Inc. engages in the design, manufacture, and distribution of orthopedic devices and supplies. Its products are used primarily by orthopedic medical specialists and spinal neurosurgeons in both surgical and non-surgical therapy. The company was founded on December 13, 2016 and is headquartered in Warsaw, IN.

CeNeS Pharmaceuticals Plc engages in the discovery and development of drugs. The company was founded by Alan Gilbert Goodman in 1997 and is headquartered in Cambridge, the United Kingdom.

Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK.

Part of Assicurazioni Generali SpA, Generali Deutschland Versicherung AG provides insurance brokerage services. The company is based in Aachen, Germany. The German company was founded in 1825 by David Hansemann. Christoph Schmallenbach has been the CEO of the company since 2015.

Avlar Ltd. (Avlar BioVentures) is a venture capital firm founded in 1999 by Alan Goodman and Daniel Roach. The firm is headquartered in Cambridge, United Kingdom.

Grünenthal GmbH engages in the research and development of pharmaceutical products. It specializes in pain, gout, and inflammation. The company was founded by Hermann Wirtz in 1946 and is headquartered in Aachen, Germany.

Arrow Therapeutics Ltd. operates as a pharmaceutical company that focuses on research and development of novel antiviral drugs. Its products include novel antibacterial, antiviral, antifungal and preclinical compounds. The company was founded in 1998 and is headquartered in Cambridge, the United Kingdom.

Microbio Group Ltd. manufactures organic fertilizers and crop protection products. The company is headquartered in Littlehampton, GB.

Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland.

NOXXON Pharma AG operates a clinical stage biotechnology company. Its core focus is on cancer treatment. The firm offers effectiveness of cancer treatments including immuno-oncology approaches such as immune checkpoint inhibition and current standards of care such as chemotherapy and radiotherapy. The company was founded in 1997 by Sven Klussmann, Jens-Peter Fürste and Thomas Klein and is headquartered in Berlin, Germany.

Immatics Biotechnologies GmbH operates as a biopharmaceutical company that develops anti-cancer immunotherapy products. The firm specializes in the discovery and development of immunotherapy products against cancer. It develops IMA901, a combination of multiple tumor-associated peptides (TUMAPs) for the treatment of renal cell carcinoma. The company was founded by Harpreet Singh, Toni Weinschenk, Niels Emmerich, Hans Georg Rammensee, Hansjörg Schild, and Peter Brossart in 2000 and is headquartered in Tübingen, Germany.

Roche Innovation Center Copenhagen A/S discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases. The firm manufactures a pipeline of drug candidates that act selectively on disease-related ribonucleic acid to provide patients with novel treatments for both rare and common diseases. It produces pre-clinical and clinical assets for the treatment of a range of diseases including oncology, metabolic diseases, and infectious diseases. The company was founded by Matts Lundwall and Mikael Ørum on January 1, 1998 and is headquartered in Horsholm, Denmark.

Organon Biosciences NV specializes in biopharmaceutical manufacturing and distribution services. It develops products in the areas of cardiovascular disease, fertility, gynecology, anesthesia, respiratory, consumer health care, and neuroscience, immunology, animal health, and oncology. The company’s products include mometasone furoate inhalation powder, moxifloxacin, pegylated liposomal doxorubicin HCI, desogestrel, desloratadine, sun care, cold/flu medicine, foot care, follitropin beta, formoterol fumarate inhalation powder, hormone therapy, and canine vaccines. It was founded in 1923 and is headquartered in Oss, the Netherlands.

The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium.

Part of AbbVie, Inc., Epidauros Biotechnologie AG is a German company that specializes in pharmacogenomics research. The company is based in Bernried, Germany. Epidauros Biotechnologie was acquired by Clinical Data BV from Deutsche Effecten & Wechsel Beteiligungs AG on August 23, 2007 for $11.83 million.

Core Group Ltd. provides construction equipment rental services. The private company is based in Halesowen, UK. The British company was founded by Alan Gilbert Goodman.

German Cancer Research Center offers biomedical research services. It develops novel approaches to make tumor diagnosis more precise and for a treatment of cancer. The firm provides different research programs such as cell and tumor biology, functional and structural genomics, risk factors and prevention, tumor immunology, imaging and radio oncology, and translational cancer research. The company was founded in 1964 and is headquartered in Heidelberg, Germany.

Crescendo Biologics Ltd. engages in the development of new medicines based on antibody fragment technology. Its products in pipeline in dermatology include CB001, a transformational Humabody-based topical biologic for psoriasis which combines exceptional activity against a validated target with a topical route of delivery to avoid systemic side effects. The firm?s oncology products in pipeline include Humabody Multi-Specific T-Cell Engagers, Humabody Antibody Drug Conjugates and Immune Checkpoint Inhibitors. The company was founded by Michael Anthony Romanos, David Rayll Brown and John Bradshaw on November 13, 2007 and is headquartered in Cambridge, the United Kingdom.

Paion Deutschland GmbH engages in the development of pharmaceutical products. The company is headquartered in Aachen, Germany.

Consilient Health Ltd. engages in the manufacture and distribution of pharmaceuticals. The private company is based in Clonskea, Ireland, and has subsidiaries in the United Kingdom. Luke Crosbie has been the CEO of the Irish company since 2005.

ArjoHuntleigh AB manufactures and sells medical devices and solutions for mobility, lifting, and wound care. Its products include floor and ceiling lifters; slings; medical and therapeutic beds; disinfectors; and VTE prevention devices. The company is headquartered in Malmö, Sweden.

Part of PAION AG, PAION, Inc. is a pharmaceutical manufacturing company. The company is based in Mahwah, NJ.

Immatics US, Inc. develops adoptive cell therapies (ACT) for the treatment of cancer. The company’s ACT therapies are intended to use human T-cells that have been multiplied outside the body before being infused into a cancer patient. It also offers XPRESIDENT, a target discovery engine that enables users to identify, quantify, and prioritize tumor-associated peptides that are recognized by T-cells. The company was founded by Harpreet Singh-Jasuja, Toni Weinschenk, Niels Emmerich, Hans-George Rammensee, Steffen Walter, Peter Brossart and Hansjorg Schild in June 2015 and is headquartered in Houston, TX.

JSP-Invest GmbH is a private company based in Potsdam, Germany. The German company's main focus is not explicitly stated in the provided metadata. However, the company offers services and has an advisory board. Jörg Spiekerkötter has been the CEO of the company since 2011.

Part of PAION AG, Paion Holdings UK Ltd. functions as an investment holding company. The company is based in Edinburgh, UK. The British company was founded in 1996. Abdelghani Omari has been the CEO of the company since 2012.

Part of PAION AG, Paion UK Ltd. is a specialty pharmaceutical company that develops and commercializes innovative drugs for out-patient and hospital-based sedation and critical care services. Paion was founded in 1995 and is based in Cambridge, UK, with another site in Germany. Paion's vision is to become an acknowledged "PAIONeer" in sedation and critical care services. The British company's lead compound is remimazolam, an intravenous, ultra-short-acting and controllable benzodiazepine sedative/anesthetic drug candidate. The company is mainly focusing on completing the development program for procedural sedation and planning to continue the clinical development program for remimazolam in the indication general in the EU.

Vitanova Biomedical, Inc. is a biotechnology company based in the United States that focuses on improving the lives of cancer patients and healthcare professionals. The private company is based in Kerrville, TX. The company aims to achieve this through the development and commercialization of their novel light-activated intracellular acidosis platform cancer therapy. Vitanova Biomedical is currently working on preclinical evidence to support progress towards regulatory clearance and market commercialization. The company was founded by Matt Gdovin and Greg Espenhover. Tom Roberts has been the CEO of the company since 2016.

Quantum Diamond Technologies, Inc. develops and commercializes nanoscale devices. The company is headquartered in Somerville, MA.

Cognifisense, Inc. is a technology company based in Sunnyvale, CA. Cognifisense's core product is virtual reality neuropsychological therapy (VRNT), which is a patented virtual reality-based therapy designed to treat chronic pain. The therapy combines psychological therapies with the immersive power of VR to address the maladaptive neuroplastic changes in the brain that drive chronic pain. The company was founded by Tassilo Baeuerle and Harald F. Stock, with Tassilo Baeuerle serving as CEO since incorporation.

Domus Diagnostics, Inc. is a company that aims to create affordable, user-friendly, accurate, and rapid tests for infectious diseases to address the needs raised by current and future public health crises. Domus Diagnostics seeks to change how infectious disease testing is done worldwide, with the goal of providing home testing for everyone, everywhere, to prevent future pandemics. The company was founded by John Reif, Harald F. Stock, and Xin Song, and is co-located in Durham and Park City, UT, with a product testing lab at the Research Triangle Park in North Carolina.

Dr. Loges + Co. GmbH is a German company that specializes in producing lipowheat extract, osteoporosis medication, phytopharmaceuticals, homeopathic remedies, and vital supplements. The private company is based in Winsen, Germany, and the CEOs are Gregor Loges and Carsten Timmering. The company also offers well-aging products that provide natural support for the body and mind. The company provides information and downloads about their products and active ingredients, as well as a pharmacy locator and reimbursement eligibility check in their service section.